A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Clinical Trial ID NCT01256073

PubWeight™ 2.53‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01256073

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immune checkpoint inhibitors in clinical trials. Chin J Cancer 2014 0.98
2 Natural killer cells modulation in hematological malignancies. Front Immunol 2013 0.88
3 Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer. Expert Opin Biol Ther 2016 0.76
Next 100